North America Smoking Cessation Aids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Smoking Cessation Aids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Smoking Cessation Aids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Smoking Cessation Aids Market Regional Analysis

6.2 North America Smoking Cessation Aids Market Revenue 2019-2028 (US$ Million)

6.3 North America Smoking Cessation Aids Market Forecast Analysis

7. North America Smoking Cessation Aids Market Analysis – by Product

7.1 Nicotine Replacement Therapy

7.1.1 Overview
7.1.2 Nicotine Replacement Therapy: North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Drugs

7.2.1 Overview
7.2.2 Drugs: North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Electronic Cigarettes

7.3.1 Overview
7.3.2 Electronic Cigarettes: North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Smoking Cessation Aids Market Analysis – by End User

8.1 Hospital Pharmacies

8.1.1 Overview
8.1.2 Hospital Pharmacies: North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Online Channel

8.2.1 Overview
8.2.2 Online Channel: North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Retail Pharmacies

8.3.1 Overview
8.3.2 Retail Pharmacies: North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Other End Users

8.4.1 Overview
8.4.2 Other End Users : North America Smoking Cessation Aids Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Smoking Cessation Aids Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Smoking Cessation Aids Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 North America Smoking Cessation Aids Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 US: North America Smoking Cessation Aids Market Breakdown, by Product
9.2.1.1.2 US: North America Smoking Cessation Aids Market Breakdown, by End User

9.2.1.2 Canada: North America Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Canada: North America Smoking Cessation Aids Market Breakdown, by Product
9.2.1.2.2 Canada: North America Smoking Cessation Aids Market Breakdown, by End User

9.2.1.3 Mexico : North America Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 Mexico : North America Smoking Cessation Aids Market Breakdown, by Product
9.2.1.3.2 Mexico : North America Smoking Cessation Aids Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Pfizer Inc.

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 GlaxoSmithKline plc.

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Dr. Reddy's Laboratories

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Johnson and Johnson Services, Inc.

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Cipla Inc.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Perrigo Company plc

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Bausch Health Companies Inc.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Glenmark

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 NJOY

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 Juul Labs

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Smoking Cessation Aids Market

Analysis By Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, and Others) and End User (Hospital Pharmacies, Online Channel, Retail Pharmacies, and Other End Users)